Abstract
Since 2001, Nuclear and Energy Research Institute IPEN-CNEN has produced weekly ultrapure iodine-123, using a manual irradiation system, fully developed in IPEN. Iodine-123 radiopharmaceuticals have been produced and distributed to hospitals and clinics of nuclear medicine, where several diagnostic imaging procedures for thyroid, brain and cardiovascular functions are performed. Due to the short half-life and emission of low-energy photons, this radioisotope becomes suitable for diagnosis in children. In the present work, the technical and constructive aspects of a new fully automated irradiation system, dedicated to 123I routine production, employing enriched xenon-124 gas as the target material is presented. This new system consists of a target, a water and helium cooling system, a cryogenic system, an electric power system, and a control and process monitoring unit, composed of supervisory software, connected to a programmable logic controller via personal computer. In this new concept, there is no need for human intervention during radioisotope production, reducing the possibility of eventual failures or incidents involving radioactive material. By using this new system, a specific yield of 2.70 mCi/μAh per irradiation was achieved in validation runs, and after three years of routine production of iodine-123, the system showed reliability and resilience.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
